Oceania · Markets & Finance · Stockhead

Optiscan’s digital pathology tech hits major US FDA milestone

Published by Stockhead · Australia 4 h ago

The submission takes InForm beyond internal development, testing and validation and into the FDA’s formal regulatory assessment process. ... Read More The post Optiscan’s digital…

Read the full article on Stockhead Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stockhead.com.au)

Also worth reading

Business News (WA)

Almost $60b wiped from ASX in bond-linked bloodbath

The Motley Fool Australia

Here are the top 10 ASX 200 shares today

SmartCompany

DIY tax returns: The deadline for self-lodging sole traders is closer than you think

Fat Tail Daily

The Reverse Centaur

ABC Business

Doctors and allied health professionals walk off job en masse amid pay disputes

Financial Standard